IMbrave251: Final analysis of atezo + lenva or sora vs lenva or sora alone in locally advanced HCC previously treated with atezo and bevacizumab
#ASCO26
👉did not meet its primary OS endpoint
👉 mOS 14.6 vs 12.5 mo
🧐 New benchmark for 2L therapy in HCC
@myesmo@ASCO@ILCAnews@EASLedu
My Toolkit 🧰⚙️🪛: Self-made steerable catheter to cross the aortic valve in severe aortic stenosis
🔗https://t.co/ZFpZV7gDb6
In this article, @Obisht, Won-Keun Kim and Robert R. Flieger describe a self-made steerable catheter system using a 6F EBU guide and the stiff back end of a 0.035″ wire, combined with a hydrophilic straight-end crossing wire, to facilitate crossing of severely stenotic or calcified native or prosthetic aortic valves during TAVI.
The technique is particularly useful in horizontal aortas, bicuspid valves, and massively calcified tricuspid or bioprosthetic valves, where the conventional technique repeatedly fails.
Reviewed by Moritz Seiffert
#interventionalcardiology #CardioEd #cardioX
Tough one on call - tried to avoid intervention and hope for steroids to help improve inflammation but patient crashed… selective embolization performed to try and maintain hepatic arterial supply - although with patent PV would it matter?
What would you do?
One of the best parts of #iRad is the ability to relieve chronic #backpain, post operative #pain, and #cancer related pain using image guided procedures. Here are a few examples: selective nerve root block, hypogastric plexus block, ilioinguinal block, pudendal block. #radres
MRI is reshaping active surveillance in prostate cancer 🎯
From guiding biopsies to tracking disease with tools like PRECISE, imaging is key—but how should it be used in follow-up?
New ESUR guidance brings clarity, aiming to standardise MRI use and improve consistency across centres.
https://t.co/RLxjgqJW1c (Stephan Ursprung et al.)
6/6 🚀 Future stroke care will rely on "personalized thresholds" rather than just lesion volume. By mapping these 6 levels, we can better target new neuroprotective therapies and refine who benefits most from late-window thrombectomy. #MedTwitter#NeuroTwitter
At @JAMA_current today, 2 radiologists publish what should be the consent form for a total body MRI in healthy people
Note: "no major medical society recommends whole-body MRI screening in the general population because it is unproven, and the harms likely outweigh the benefits."
https://t.co/TRSkxDwb6K
More finds while moving.
Here are two of my father's cut-film angiograms ~1970's
Notice the technique used for the aortogram - hint: the patient was face-down 😳
Also note what to do when the aorta is occluded the only way to do a bilateral LE angiogram (takes 2 people)
Sharing my #NET local treatment algorithm here. Feel free to disagree / comment. All of these patients get discussed at MDTB
IF low Ki67 (single digit) and liver dominant
Bilobar bland embo, 2 sessions
Y90 if frail or poor performance status
IF significant extra hepatic disease or KI-67 > 20%
refer for Lutathera
When recurrence after bland embo, Y90 at low dose target (80Gy), often have two lifetime bilobar sessions
Oligometastatic disease (or <3 mets) - ablation / surgery / Y90 rad seg
#iRad
A "new era" for Post-Thrombotic Syndrome (PTS) following deep vein thrombosis (DVT)! 🦵
🔥 Hot off the press from #SIR26TOR and in the @NEJM
The #CTRACT trial delivers the first RCT validating endovascular therapy for PTS after DVT.
Let's break it down 👇🧵
Check out our recent publication in BMJ Case Reports: Transcatheter closure of an aortic root pseudoaneurysm recurring after surgical repair. Our technique highlights a combination transcatheter approach with no residual leak. Grateful to have learned from incredible operators.
Very difficult case. Chronic PVT, gastric variceal bleed. Not the typical gastrorenal anatomy. Active bleeding on venogram. Treated w coils, STS, gelfoam #iRad
Post-treatment HCC imaging is clearer. The 2024 LI-RADS TR update refines criteria for radiation vs non-radiation therapies and adds MRI features to better detect viable tumor for accurate assessment and management @guigotti92@rocharadiologia@VChernyakMD https://t.co/GfL4qDVLBZ